CLC enters distribution agreement with Medline for fentanyl screening kit
The FDA-cleared point-of-care test detects fentanyl in urine at 1.0 ng/mL cutoff in under six minutes on RYAN analyzer.
See the latest news and media coverage for CLC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of clinical diagnostic analyzers and reagents
carolinachemistries.comLast updated
In short: CLC was acquired by Diazyme Laboratories, Inc. and received several regulatory categorizations for its clinical diagnostic assays and reagents.
The FDA-cleared point-of-care test detects fentanyl in urine at 1.0 ng/mL cutoff in under six minutes on RYAN analyzer.
Superbio received clearance for the RYAN analyzer detecting fentanyl at 1.0 ng/mL cutoff. Results in under 6 minutes. Partners with Bioeasy USA.
U.S. District Judge dismissed all claims against CLC in Northern District of California. The court found no evidence linking CLC to false claims and confirmed FDA clearance for devices.
The partnership adds 25 new assays totaling over 45 CLIA-categorized assays. It enables clinical labs to run special and routine chemistries efficiently on the benchtop analyzer.
Diazyme Laboratories, Inc. announced today that it has acquired the business of Carolina Liquid Chemistries Corporation (CLC). CLC is an FDA registered manufacturer, and value-added...
An ethyl alcohol (ETOH) assay from Carolina Liquid Chemistries Corp. (CLC) has been categorized as moderately complex under the Clinical Laboratory Improvement Amendments of 1988...
GREENSBORO, N.C., Oct. 12, 2021 /PRNewswire/ -- Carolina Liquid Chemistries Corp. (CLC) announces it has received certification as a Veteran-Owned Small Business (VOSB) and been...
Track CLC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CLC and other trending companies.